Symposia: Outcomes Research—Lymphoid Malignancies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Lymphoid Leukemias, Lymphomas, Clinical Practice (Health Services and Quality), epidemiology, CLL, Non-Biological therapies, non-Hodgkin lymphoma, elderly, Clinical Research, health outcomes research, B Cell lymphoma, Combination therapy, T Cell lymphoma, Diseases, indolent lymphoma, patient-reported outcomes, real-world evidence, Therapies, aggressive lymphoma, Lymphoid Malignancies, Adverse Events, survivorship, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Lymphoid Leukemias, Lymphomas, Clinical Practice (Health Services and Quality), epidemiology, CLL, Non-Biological therapies, non-Hodgkin lymphoma, elderly, Clinical Research, health outcomes research, B Cell lymphoma, Combination therapy, T Cell lymphoma, Diseases, indolent lymphoma, patient-reported outcomes, real-world evidence, Therapies, aggressive lymphoma, Lymphoid Malignancies, Adverse Events, survivorship, Study Population, Human
Monday, December 12, 2022: 10:30 AM-12:00 PM
388-390
(Ernest N. Morial Convention Center)
Moderators:
Jean L. Koff, MD, MSc, Emory University
and
Ning Dong, H. Lee Moffitt Cancer Center and Research Institute
Disclosures:
No relevant conflicts of interest to declare.
This session gives the updates and outcomes in conditions related to lymphoma
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH